Browsing Tag
MALT1 inhibitor
1 post
Schrödinger earns FDA Fast Track for SGR-1505 in Waldenström macroglobulinemia amid rising therapeutic demand
Schrödinger’s SGR-1505 receives FDA Fast Track designation for Waldenström macroglobulinemia, highlighting a novel MALT1-targeted approach.